戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 llowing detection of the beta-lactam, of the AmpC beta-lactamase.
2 n organisms lacking a chromosomally mediated AmpC beta-lactamase.
3  1 nM inhibitor (compound 1) in complex with AmpC beta-lactamase.
4 o detect phenotypically isolates that harbor AmpC beta-lactamase.
5 extended-spectrum beta-lactamases (ESBL) and AmpC beta-lactamases.
6 ve infections caused by organisms expressing AmpC beta-lactamases.
7 sensitive and specific for detecting SHV and AmpC beta-lactamases.
8 btained only for isolates producing ESBLs or AmpC beta-lactamases.
9                                        Using AmpC beta-lactamase, an enzyme that is well-characterize
10 ere obtained for seven of eight producers of AmpC beta-lactamase and no ESBL producers.
11 g/ml were obtained for all strains producing AmpC beta-lactamase and only 1 of 33 strains producing E
12  correlate well for isolates containing both AmpC beta-lactamases and ESBLs.
13 um beta-lactamases (ESBLs), plasmid-mediated AmpC beta-lactamases and KPC carbapenemases in Enterobac
14 o be very potent inhibitors of the TEM-1 and AmpC beta-lactamases and less so against the class B met
15 sistent with production of both a TEM and an AmpC beta-lactamase, and representative isolates of seve
16 ectrum beta-lactamases (ESBLs), transferable AmpC beta-lactamases, and carbapenemases are associated
17  isolates) producing non-MBL carbapenemases, AmpC beta-lactamases, and extended-spectrum beta-lactama
18 ted antibiotic-resistant proteins, including AmpC, beta-lactamase, and carO, in clinical resistant st
19                                              AmpC beta-lactamases are cephalosporinases that confer r
20 gative organisms expressing plasmid-mediated AmpC beta-lactamases are limited because these organisms
21                       Unlike ESBLs, however, AmpC beta-lactamases are not inhibited by clavulanic aci
22                                              AmpC beta-lactamases are related to the chromosomal enzy
23                                          For AmpC beta-lactamase, binding to aggregates of the small
24 MY-2 antibody was tested against a number of AmpC beta-lactamases by assaying known quantities of pur
25 e m-aminophenylboronic acid-Escherichia coli AmpC beta-lactamase complex to suggest modifications tha
26 tibiotic resistance genes, including a FOX-5 AmpC beta-lactamase encoded on a large IncA/C plasmid.
27 g family-specific ampC genes responsible for AmpC beta-lactamase expression in organisms with or with
28 deficient Q120L/Y150E variant of the class C AmpC beta-lactamase from Escherichia coli was solved at
29                            The structures of AmpC beta-lactamase from Escherichia coli, alone and in
30 ositive isolates were positive by PCR for an AmpC beta-lactamase gene.
31 n in organisms with or without a chromosomal AmpC beta-lactamase gene.
32 r the purpose of identifying family-specific AmpC beta-lactamase genes within gram-negative pathogens
33                             Plasmid-mediated AmpC beta-lactamases have been associated with false in
34                       Plasmid-mediated CMY-2 AmpC beta-lactamases have been identified in Salmonella
35             Six families of plasmid-mediated AmpC beta-lactamases have been identified, but no phenot
36 eumoniae bloodstream isolates harbor ESBL or AmpC beta-lactamases, (ii). confirmatory tests are neces
37 a 1.07 A X-ray crystallographic structure of AmpC beta-lactamase in complex with a boronic acid deacy
38 ng frequency, the true rate of occurrence of AmpC beta-lactamases in Escherichia coli, Klebsiella pne
39  in all gram-negative isolates, transferable AmpC beta-lactamases in Klebsiella pneumoniae, and carba
40 ere evaluated for detecting plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia col
41 nient means of detection of plasmid-mediated AmpC beta-lactamases in organisms lacking a chromosomall
42                The diagnostic utility of the AmpC beta-lactamase inhibitors LN-2-128, 48-1220, and Sy
43           In particular, derepression of the AmpC beta-lactamase is a common mechanism of beta-lactam
44          Inducible expression of chromosomal AmpC beta-lactamase is a major cause of beta-lactam anti
45 boronic acid (BZB), a nanomolar inhibitor of AmpC beta-lactamase (K i = 27 nM), we have identified an
46 ither the class C Citrobacter freundii CMY-2 AmpC beta-lactamase nor the class A TEM-1 beta-lactamase
47 ta-lactam antibiotics induce the chromosomal ampC beta-lactamase of many gram-negative bacteria.
48 ae P99, Klebsiella pneumoniae ACT-1, and the AmpC beta-lactamases of Enterobacter aerogenes, Morganel
49 wn quantities of purified enzymes in ELISAs (AmpC beta-lactamases of M. morganii, C. freundii, E. col
50 x, and periplasmic degradation (catalyzed by AmpC beta-lactamase) of these two compounds, and correla
51 m beta-lactamase (ESBL) and plasmid-mediated AmpC beta-lactamase (pAmpC) genes.
52 f Klebsiella spp. producing plasmid-mediated AmpC beta-lactamases (pAmpCs) was evaluated.
53    In patients with organisms hyperproducing AmpC beta-lactamases (positive by both methods), clinica
54 ity score matching of patients infected with AmpC beta-lactamase-positive organisms treated with cefe
55  extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase producers.
56                                              AmpC beta-lactamase-producing organisms are associated w
57 spectrum beta-lactamase-producing organisms, AmpC beta-lactamase-producing organisms, carbapenem-resi
58  the treatment of invasive infections due to AmpC beta-lactamase-producing organisms, particularly wh
59 eria, 96 (24%) had confirmed infections with AmpC beta-lactamase-producing organisms.
60 cloxacillin Etest to identify organisms with AmpC beta-lactamase production from February 2010 to Jan
61 vious microarray studies have shown that the AmpC beta-lactamase regulator AmpR, a member of the LysR
62  did not recognize TEM-1, K-1, OXA-1, or any AmpC beta-lactamase tested.
63 tion of organisms producing plasmid-mediated AmpC beta-lactamases, we evaluated the diagnostic utilit
64                                 Transferable AmpC beta-lactamases were detected in 3.3% of K. pneumon
65                    Although plasmid-mediated AmpC beta-lactamases were first reported in the late 198
66 , organisms producing ESBLs and transferable AmpC beta-lactamases were widespread.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。